Human Papilloma Virus DNA in Tumor Tissue and Urine in Different Stage of Bladder Cancer
Vol. 16 No. 4 (2019),
18 August 2019
Purpose: There are some previous reports on the relationship between pathological grades and HPV detection. To determine the Human Papilloma Virus(HPV) DNA in Tumor Tissue and Urine in Different Stage of Bladder Cancer conducted this study.
Materials and Methods: Polymerase chain reaction (PCR) was used to detect general HPV and HPV16 and 18 subtypes in 110 bladder tumor tissue and urine specimens of patients with TCC of bladder between January 2014 to May 2016 that underwent transurethral resection of bladder tumor. Exclusion criteria were genital wart and cases with immunosupression.
Results: Mean age of 110 patients was 61.6±10 years and fourteen (12.7%) of patients were female. PCR for general HPV primer in bladder tumor tissue was positive in 3 (9.4%), 22 (38.6%) and 15 (71.4%) of Ta, T1 and T2 bladder tumors, respectively (p<0.001). PCR for HPV16 in bladder tumor tissue was positive in 2(6.3%), 10 (17.5%) and 13 (61.9%) and PCR for HPV18 in bladder tumor tissue was positive in 1 (3.1%), 14 (24.6%) and 12 (57.1%) of Ta, T1 and T2 bladder tumors, respectively (p<0.001, p<0.001). Thirty seven (33.6%) of urine specimens were positive for general HPV using PCR and HPV16 and 18 subtypes were positive in 17 (15.5%) and 14 (12.7%) of urine specimens, respectively.
Conclusion: HPV infection may be associated with higher stages and grades of bladder carcinomas. Urine sampling for HPV detection is is as reliable as tumor tissue sample which could be considered for prognostic and follow up implications.
Ben Selma W, Ziadi S, Ben Gacem R, Amara K, Ksiaa F, Hachana M, Trimeche M. Investigation of human papillomavirus in bladder cancer in a series of Tunisian patients. Pathol Res Pract2010 Nov 15;206(11):740-3.
Badawi H, Ahmed H, Ismail A, Diab M, Moubarak M, Badawy A, Saber M. Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients. Medscape J Med2008;10(10):232.
Knowles MA. Human papillomavirus sequences are not detectable by Southern blotting or general primer-mediated polymerase chain reaction in transitional cell tumours of the bladder. Urol Res1992;20(4):297-301.
Anwar K, Naiki H, Nakakuki K, Inuzuka M. High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer1992 Oct 1;70(7):1967-73.
Aggarwal S, Arora VK, Gupta S, Singh N, Bhatia A. Koilocytosis: correlations with high-risk HPV and its comparison on tissue sections and cytology, urothelial carcinoma. Diagn Cytopathol2009 Mar;37(3):174-7.
Barghi MR, Hajimohammadmehdiarbab A, Moghaddam SM, Kazemi B. Correlation between human papillomavirus infection and bladder transitional cell carcinoma. BMC Infect Dis2005;5:102.
De Gaetani C, Ferrari G, Righi E, Bettelli S, Migaldi M, Ferrari P, Trentini GP. Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridisation. J Clin Pathol1999 Feb;52(2):103-6.
Lopez-Beltran A, Escudero AL. Human papillomavirus and bladder cancer. Biomed Pharmacother 1997;51:252-7.
Furihata M, Inoue K, Ohtsuki Y, Hashimoto H, Terao N, Fujita Y. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res1993 Oct 15;53(20):4823-7.
Barghi MR, Rahjoo T, Borghei M, Hosseini-Moghaddam SM, Amani D, Farrokhi B. The association between the evidence of human papillomavirus infection in bladder transitional cell carcinoma in men and the cervical dysplasia in their spouses. Arch Iran Med. 2012; 15(9): 572 – 574.
Shimada M, Fukushima M, Mukai H, Kato I, Nishikawa A, Fujinaga K. Amplification and specific detection of transforming gene region of human papillomavirus 16, 18 and 33 in cervical carcinoma by means of the polymerase chain reaction. Jpn J Cancer Res1990 Jan;81(1):1-5.
Mvula M, Iwasaka T, Iguchi A, Nakamura S, Masaki Z, Sugimori H. Do human papillomaviruses have a role in the pathogenesis of bladder carcinoma? J Urol1996 Feb;155(2):471-4.
zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res1989 Sep 1;49(17):4677-81.
Kitamura T, Yogo Y, Ueki T, Murakami S, Aso Y. Presence of human papillomavirus type 16 genome in bladder carcinoma in situ of a patient with mild immunodeficiency. Cancer Res1988 Dec 15;48(24 Pt 1):7207-11.
LaRue H, Simoneau M, Fradet Y. Human papillomavirus in transitional cell carcinoma of the urinary bladder. Clin Cancer Res1995 Apr;1(4):435-40.
Youshya S, Purdie K, Breuer J, Proby C, Sheaf MT, Oliver RT, Baithun S. Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. J Clin Pathol2005 Feb;58(2):207-10.
Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell1990 Dec 21;63(6):1129-36.
Tenti P, Zappatore R, Romagnoli S, Civardi E, Giunta P, Scelsi R, Stella G, Carnevali L. p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters. J Pathol1996 Jan;178(1):65-70.
Kamel D, Paakko P, Pollanen R, Vahakangas K, Lehto VP, Soini Y. Human papillomavirus DNA and abnormal p53 expression in carcinoma of the urinary bladder. APMIS1995 May;103(5):331-8.
Lopez-Beltran A, Escudero AL, Vicioso L, Munoz E, Carrasco JC. Human papillomavirus DNA as a factor determining the survival of bladder cancer patients. Br J Cancer1996 Jan;73(1):124-7.
Moonen PM, Bakkers JM, Kiemeney LA, Schalken JA, Melchers WJ, Witjes JA. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur Urol2007 Aug;52(2):464-8.
Melchers WJ, Schift R, Stolz E, Lindeman J, Quint WG. Human papillomavirus detection in urine samples from male patients by the polymerase chain reaction. J Clin Microbiol1989 Aug;27(8):1711-4.
Forslund O, Hansson BG, Rymark P, Bjerre B. Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples. J Clin Microbiol1993 Aug;31(8):1975-9.
Jacobson DL, Womack SD, Peralta L, Zenilman JM, Feroli K, Maehr J, Daniel RW, Shah KV. Concordance of human papillomavirus in the cervix and urine among inner city adolescents. Pediatr Infect Dis J2000 Aug;19(8):722-8.
- Abstract Viewed: 750 times
- PDF/4181 Downloaded: 303 times